Due primarily to political threats, promises and upheaval, there was a pullback not long ago in the prices of many health care stocks, and I often like to take advantage of such investing opportunities.
It very well might be the all-time favorite company of Dividend Growth Investing proponents.
It will be the 32nd purchase in our Income Builder Portfolio.
It’s been a strong performer for decades, not just as a stock that has crushed the overall market in total return but as a company that has grown earnings, revenues, free cash flow and dividends year after year after year.
It will be the 31st purchase in our Income Builder Portfolio.
If you had told me 15 months ago that the companies we’d select for the IBP would combine to outperform the market nearly 2-to-1 while also positioning the portfolio to produce almost $1,000 in annual income, I would have done my happy dance right then and there.
Its valuation metrics look very favorable right now.
It will be the 30th purchase in our Income Builder Portfolio.
Shares aren’t a bargain, but I’m always willing to consider an outstanding company at fair value.
It will be the 29th purchase in our Income Builder Portfolio
